{
  "hits": 306,
  "size": 50,
  "data": [
    {
      "title": "吡咯替尼新辅助获批，创新药逐渐进入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-06-07 00:00:00.000",
      "infoCode": "AP202206071570559730",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1157,
      "attachPages": 4,
      "encodeUrl": "cx1sB5M0EnBhZoCs5tzHP4KBhngdFpRr0XLOtiW/i/0=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "抗肿瘤创新药亮相ASCO，瑞维鲁胺（ARi）、“双艾”等数据亮眼",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2022-06-05 00:00:00.000",
      "infoCode": "AP202206041569990009",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 698,
      "attachPages": 5,
      "encodeUrl": "BAMShNhRNKtLwRSm7yRoikGGcYx0PCIHsbYd37dwWMY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "地夸磷索钠滴眼液首仿上市，创仿结合战略深化",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2022-05-31 00:00:00.000",
      "infoCode": "AP202205311569076987",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1130,
      "attachPages": 4,
      "encodeUrl": "Grok5yDTRek2nwp1wmflF29VtN4sBRXtCLu41Xa17K8=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "碘克沙醇注射液美国首仿上市，国际化持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2022-05-27 00:00:00.000",
      "infoCode": "AP202205271568235686",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 906,
      "attachPages": 4,
      "encodeUrl": "oGkes2vZ/o1mjSN40ihWtRYYPrls+IcJ/JsOATORdeE=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "碘克沙醇美国首仿获批，仿创结合推进国际化",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-05-26 00:00:00.000",
      "infoCode": "AP202205261567959875",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1182,
      "attachPages": 4,
      "encodeUrl": "1bGTiwySBv/W8qTUebGYeiyfErySVboRstxO0kQv9JY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "国际化如期推进，PD-1国际多中心III期成功",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-05-13 00:00:00.000",
      "infoCode": "AP202205131565313772",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1191,
      "attachPages": 4,
      "encodeUrl": "PO7cx/aL+Hs5WqUY6Isr+sAPfVgMIvbpVt/0dT7LYJA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021年报和2022一季报点评：短期业绩承压，持续看好研发战略布局",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2022-04-26 00:00:00.000",
      "infoCode": "AP202204261561673357",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 396,
      "attachPages": 3,
      "encodeUrl": "zO5QHhTcvhJXq9bbavH+j27yATn12P6PS5ZX7Ezy6S8=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021年年报和2022年一季报点评：集采影响逐渐消化，创新药进入良性循环",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2022-04-26 00:00:00.000",
      "infoCode": "AP202204261561589789",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 518,
      "attachPages": 3,
      "encodeUrl": "zO5QHhTcvhJXq9bbavH+jzFUHUSNSM5JGHjIo0M0Pdo=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "集采短期影响持续，创新与国际化快速推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2022-04-25 00:00:00.000",
      "infoCode": "AP202204251561499323",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1273,
      "attachPages": 5,
      "encodeUrl": "vQgSeAUTa9tQ3HzvGiks547hJIOD6e11xlsjVUKSCuc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新转型过渡期，坚持加大研发投入",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-04-24 00:00:00.000",
      "infoCode": "AP202204241561240468",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1249,
      "attachPages": 4,
      "encodeUrl": "f5oQd6RGfnkuwnk2IUDxfwgMSWt4LYZbchJh2LpqJiE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "回购股份完善员工激励，彰显公司信心",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-03-15 00:00:00.000",
      "infoCode": "AP202203151552708442",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9990000000",
      "predictLastYearPe": "37.6500000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1118,
      "attachPages": 4,
      "encodeUrl": "GdxTjwLuSnILBWM6GcARjJHs/89HjRE5VArL4TEe/rs=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "再添2款新药上市，创新药逐步迎来收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-01-04 00:00:00.000",
      "infoCode": "AP202201041538443396",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9980000000",
      "predictLastYearPe": "49.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1113,
      "attachPages": 4,
      "encodeUrl": "G7QS+dnH0wtAnJEGTekuChfz2WEZjP+4Qcl5UX/vlhg=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "【粤开医药公司点评】恒瑞医药：两款创新药获批上市，拥抱全面创新",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000118",
      "orgName": "粤开证券股份有限公司",
      "orgSName": "粤开证券",
      "publishDate": "2022-01-03 00:00:00.000",
      "infoCode": "AP202201031538270016",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.03",
      "predictLastYearPe": "49.28",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000246431.陈梦洁"
      ],
      "indvIsNew": "001",
      "researcher": "陈梦洁",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1046,
      "attachPages": 5,
      "encodeUrl": "LF+PLSWiaofMSuh8YPx2pdq2IFs2hYAcmcXxsVZWFBc=",
      "sRatingName": "增持",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000246431"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药全部纳入医保，即将迎来全面放量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2021-12-06 00:00:00.000",
      "infoCode": "AP202112061533172349",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1123,
      "attachPages": 4,
      "encodeUrl": "7rAK8bLoVA2q1k66D4ostPL2xHuTwjBr4XaW/KXtRDI=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞与基石强强联合，加速创新转型",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2021-11-23 00:00:00.000",
      "infoCode": "AP202111231530656698",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1504,
      "attachPages": 8,
      "encodeUrl": "R+M2QJqOGv0Ky9vYM/QPP4+s04CRN2ERlTiHu1kqaBo=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021三季报点评：短期业绩承压，看好公司长期创新转型",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2021-10-21 00:00:00.000",
      "infoCode": "AP202110211524078476",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 371,
      "attachPages": 3,
      "encodeUrl": "PkrBgcvcw/xGrJcWFUeKME54eH6enWhf+RGGN9OsQdQ=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "转型阵痛期，加速创新研发及国际化",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2021-10-21 00:00:00.000",
      "infoCode": "AP202110211524056249",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1105,
      "attachPages": 4,
      "encodeUrl": "PkrBgcvcw/xGrJcWFUeKMGNv0mMHy+kg+ueEOBAEMUk=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "集采短期持续影响业绩，全面拥抱创新与国际化",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-10-20 00:00:00.000",
      "infoCode": "AP202110201523915767",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1306,
      "attachPages": 5,
      "encodeUrl": "njw1tH007Ud9+w6yUWiU5dte+VAkwsmTISDq9nfBCoc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入增速放缓，全面创新升级",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2021-10-20 00:00:00.000",
      "infoCode": "AP202110201523906474",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏",
        "11000337032.陈成"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏,陈成",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 481,
      "attachPages": 5,
      "encodeUrl": "njw1tH007Ud9+w6yUWiU5TNx+wxoWP44rA5hw9D42mM=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031",
        "11000337032"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "BD引进再度出手，喜提第三代抗CD20单抗",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-09-06 00:00:00.000",
      "infoCode": "AP202109061514565994",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1148,
      "attachPages": 4,
      "encodeUrl": "TwCr5m6lcMhpWT6Yz63F4axRbfEEU2dszhEKcgoyOSI=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "普那布林-公司对外BD合作新纪元",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-09-01 00:00:00.000",
      "infoCode": "AP202108311513443449",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1191,
      "attachPages": 4,
      "encodeUrl": "J9xAyD7AeEKwIXuWzA9mxK15kcpqpxOVfmDi1/C3DQg=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021年中报点评：受集采影响公司业绩承压，创新与国际化转型持续加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2021-08-24 00:00:00.000",
      "infoCode": "AP202108241512070358",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 610,
      "attachPages": 3,
      "encodeUrl": "S2S3ocsW4GX3DDkxwIpVkJjaltQn8kg7Qme3aYgvJcA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "多因素影响短期业绩，创新国际化将迎质变",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-08-23 00:00:00.000",
      "infoCode": "AP202108231511801358",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1198,
      "attachPages": 4,
      "encodeUrl": "AwMQ4pCgWE4lXn/vHxWDVETJslJutoRlf+dGYWE9lmw=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "研发投入加大，国际化进程提速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2021-08-22 00:00:00.000",
      "infoCode": "AP202108221511633673",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1254,
      "attachPages": 4,
      "encodeUrl": "dAUuu7G4qbfmuBiBBFzgJ+W7KPvnDNSS82jlnCQrYTQ=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021半年报点评：研发力度加大，创新支撑成长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券",
      "orgSName": "中航证券",
      "publishDate": "2021-08-22 00:00:00.000",
      "infoCode": "AP202108221511595369",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 423,
      "attachPages": 3,
      "encodeUrl": "dAUuu7G4qbfmuBiBBFzgJ73StKEsKAo4OdqZ953GXCU=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2021年中报点评：仿制药及PD1承压，加码国内外管线布局",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2021-08-22 00:00:00.000",
      "infoCode": "AP202108221511585799",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000283533.徐偲"
      ],
      "indvIsNew": "001",
      "researcher": "徐偲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1217,
      "attachPages": 3,
      "encodeUrl": "dAUuu7G4qbfmuBiBBFzgJzXdXAim5RDH0DLP638nqJQ=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000283533"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩短期承压，创新国际化提速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2021-08-20 00:00:00.000",
      "infoCode": "AP202108201511214654",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏",
        "11000337032.陈成"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏,陈成",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 540,
      "attachPages": 5,
      "encodeUrl": "/qg68gUR8fuai/8iEKgHGEyrdITYN4lXD56hIHzF7Ew=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031",
        "11000337032"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021年中报点评：仿制药销售下滑拖累业绩",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2021-08-20 00:00:00.000",
      "infoCode": "AP202108201511186817",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 446,
      "attachPages": 3,
      "encodeUrl": "/qg68gUR8fuai/8iEKgHGIbXks2ZzYPWk5gw5e/h9Ks=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000179188"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司信息更新报告：海曲泊帕获批上市，创新药梯队持续完善",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000162",
      "orgName": "开源证券股份有限公司",
      "orgSName": "开源证券",
      "publishDate": "2021-06-23 00:00:00.000",
      "infoCode": "AP202106231499538777",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "0.99206473800514",
      "actualLastYearEps": "0.99206473800514",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000257943.苑建",
        "11000274331.蔡明子",
        "11000251232.王斌"
      ],
      "indvIsNew": "001",
      "researcher": "苑建,蔡明子,王斌",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 893,
      "attachPages": 6,
      "encodeUrl": "UvQ9uh7uaCBxjw2rFp4yjfpEh9Ky8Tf+Dvurd/mk218=",
      "sRatingName": "买入(Buy)",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000257943",
        "11000274331",
        "11000251232"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2021年恒瑞医药企业研究报告",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81084604",
      "orgName": "头豹研究院",
      "orgSName": "头豹研究院",
      "publishDate": "2021-05-11 00:00:00.000",
      "infoCode": "AP202105111491054439",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000332734.郝世超"
      ],
      "indvIsNew": "001",
      "researcher": "郝世超",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2829,
      "attachPages": 41,
      "encodeUrl": "3a3+nYiS8tr5pGxmEbEajFuFoTBiwKx84xjeiOTgTzI=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000332734"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药快速放量，看好发展前景",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2021-04-23 00:00:00.000",
      "infoCode": "AP202104231487249102",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000330431.孟令伟",
        "11000330432.刘晖"
      ],
      "indvIsNew": "001",
      "researcher": "孟令伟,刘晖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 799,
      "attachPages": 6,
      "encodeUrl": "P0Vp/3gkuYU/ynPITcfn+3aAzlPNUrYDsEhtEO4smNE=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000330431",
        "11000330432"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2020年报点评：肿瘤业务维持高增长，研发创新持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券",
      "orgSName": "中航证券",
      "publishDate": "2021-04-22 00:00:00.000",
      "infoCode": "AP202104221487033624",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 353,
      "attachPages": 3,
      "encodeUrl": "PrVaIQY67yvgxrIw9luMBRj4Xrss4Y9eNBtDWY5u68Y=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2020年及1Q21业绩：业绩符合市场预期，重磅新药持续放量（附会议纪要）",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81070432",
      "orgName": "浦银国际证券有限公司",
      "orgSName": "浦银国际证券",
      "publishDate": "2021-04-22 00:00:00.000",
      "infoCode": "AP202104221487031450",
      "column": "002004006001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000327631.朱倩岚",
        "11000344534.胡泽宇"
      ],
      "indvIsNew": "001",
      "researcher": "朱倩岚,胡泽宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1123,
      "attachPages": 11,
      "encodeUrl": "PrVaIQY67yvgxrIw9luMBeLGT09GFImlIf5Q4LjZr4o=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000327631",
        "11000344534"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "肿瘤板块表现亮眼，持续加大研发投入",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-04-21 00:00:00.000",
      "infoCode": "AP202104211486877412",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1473,
      "attachPages": 4,
      "encodeUrl": "cobT9IQStnnPUd1w51MjxyrRhVHJtaawu4OXPe6B7dc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药快速放量，业绩符合预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2021-04-21 00:00:00.000",
      "infoCode": "AP202104211486858288",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏",
        "11000337032.陈成"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏,陈成",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 475,
      "attachPages": 5,
      "encodeUrl": "cobT9IQStnnPUd1w51Mjx/Fh2/BudGH9l+2kmfCc3CY=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031",
        "11000337032"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "股权激励费用和研发费用影响一季度业绩，创新增长动能持续",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2021-04-21 00:00:00.000",
      "infoCode": "AP202104211486839290",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "王睿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 662,
      "attachPages": 5,
      "encodeUrl": "cobT9IQStnnPUd1w51MjxyXx5s7Hu4Gv7SvSlysi3m0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000308731"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2020年报暨2021Q1季报点评：业绩逐渐回暖，医保放量可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2021-04-21 00:00:00.000",
      "infoCode": "AP202104211486828657",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000309636.刘慧敏"
      ],
      "indvIsNew": "001",
      "researcher": "刘慧敏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1513,
      "attachPages": 10,
      "encodeUrl": "cobT9IQStnnPUd1w51Mjx3p7g+vrZwIuM4H/xdcBEls=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000309636"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药快速增长，研发投入不断增强",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2021-04-21 00:00:00.000",
      "infoCode": "AP202104211486826926",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1002,
      "attachPages": 4,
      "encodeUrl": "cobT9IQStnnPUd1w51MjxwI4byZqUO4DFmbaEgwh7sE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2020年年报及2021一季报点评：持续加大研发投入，业绩稳健增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2021-04-21 00:00:00.000",
      "infoCode": "AP202104211486720885",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 625,
      "attachPages": 3,
      "encodeUrl": "cobT9IQStnnPUd1w51Mjx3xIljAzKWCvnb9iDK9ZZBA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司信息更新报告：创新药快速放量，研发投入不断增强",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000162",
      "orgName": "开源证券股份有限公司",
      "orgSName": "开源证券",
      "publishDate": "2021-04-20 00:00:00.000",
      "infoCode": "AP202104201486612010",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000332246.王斌",
        "11000274331.蔡明子",
        "11000257943.苑建"
      ],
      "indvIsNew": "001",
      "researcher": "王斌,蔡明子,苑建",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1395,
      "attachPages": 12,
      "encodeUrl": "1xPtioW8/P7Rier6e1rWKq/SmbXBaKrujQdT7B9x/3k=",
      "sRatingName": "买入(Buy)",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000332246",
        "11000274331",
        "11000257943"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2020年报及2021年一季报点评：抗肿瘤药物保持快增 持续加大研发投入",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2021-04-20 00:00:00.000",
      "infoCode": "AP202104201486580164",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 493,
      "attachPages": 4,
      "encodeUrl": "1xPtioW8/P7Rier6e1rWKpEvrCunadmxdWoKpcnIWbc=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000179188"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新出海再添新品种，加速创新国际化",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-02-24 00:00:00.000",
      "infoCode": "AP202102241464816373",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.2100000000",
      "predictLastYearPe": "83.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1452,
      "attachPages": 4,
      "encodeUrl": "vjvkEMQ0CT1ORnUaiyvlQ0ENgtFthVoWIpX02KWNkQg=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "系列研究（一）：恒瑞医药：全球视野下的创新工匠",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2021-01-04 00:00:00.000",
      "infoCode": "AP202101041446888394",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.2300000000",
      "predictLastYearPe": "93.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000266132.柴博"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,柴博",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 5322,
      "attachPages": 56,
      "encodeUrl": "L+DhCn8Ro2gSr2dqZoNJ2xArvoTSy/nuEUGA8tIk+O0=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000266132"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "CDK4/6Ⅲ期优效，乳腺癌线将迎新重磅产品",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-12-25 00:00:00.000",
      "infoCode": "AP202012251443810869",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1124,
      "attachPages": 4,
      "encodeUrl": "rG8YlTgvX4xfimU4+mMMKDys2CfGVamVXvZA4bUKg0I=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "首个国产PARP抑制剂获批，氟唑帕利前景可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2020-12-20 00:00:00.000",
      "infoCode": "AP202012201442160857",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000330431.孟令伟",
        "11000330432.刘晖"
      ],
      "indvIsNew": "001",
      "researcher": "孟令伟,刘晖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 788,
      "attachPages": 7,
      "encodeUrl": "4YZ3+cLi1BcRyVn8rcX0BPvaZ1CT9I9Oypw4Qm8oU9M=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000330431",
        "11000330432"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "PD-1适应症再扩展，助力公司脱颖而出",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2020-12-17 00:00:00.000",
      "infoCode": "AP202012171441292062",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000330431.孟令伟",
        "11000330432.刘晖"
      ],
      "indvIsNew": "001",
      "researcher": "孟令伟,刘晖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 730,
      "attachPages": 7,
      "encodeUrl": "NIMiRTbkk9Ro73NbJsA85jCaKRQHHzyzeuPZgzwUXsQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000330431",
        "11000330432"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "氟唑帕利获批，各项研发进展顺利",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2020-12-16 00:00:00.000",
      "infoCode": "AP202012161440797067",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321135.王麟"
      ],
      "indvIsNew": "001",
      "researcher": "王麟",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 672,
      "attachPages": 4,
      "encodeUrl": "PAB5u6HBMGQVE06Wc4TOWLQGkbDKlH47IeJpoHTb2dw=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321135"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药：三季度业绩增速回升，创新药格局良好",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2020-10-20 00:00:00.000",
      "infoCode": "AP202010201422540864",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 586,
      "attachPages": 5,
      "encodeUrl": "9NzypCmdc49FKCr9CLvVhZEQBmJEbD1Q5sTW4Mxjyl8=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2020年Q3点评：Q3业绩加速回升，基本符合预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-10-20 00:00:00.000",
      "infoCode": "AP202010201422518192",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2444,
      "attachPages": 20,
      "encodeUrl": "9NzypCmdc49FKCr9CLvVhUFRODlsmwBaTxw4GOX5U2Q=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000238231"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "刚需属性不改，创新驱动增长快速恢复",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-10-20 00:00:00.000",
      "infoCode": "AP202010201422497305",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1120,
      "attachPages": 4,
      "encodeUrl": "9NzypCmdc49FKCr9CLvVhQoJ4f12sOgqAgeHkBE5o1o=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    }
  ],
  "TotalPage": 7,
  "pageNo": 3,
  "currentYear": 2025
}